In short, yes, you will
Although GLP-1 medications have transformed obesity treatment, there remains a significant need for rigorous data examining how these therapies affect fertility and reproductive function in this population. The RESTORE study is currently evaluating semaglutide treatment in girls and women with PMOS and obesity, with the overarching goal of determining whether weight loss and metabolic improvements can restore ovulation and improve reproductive outcomes
The last big thing to remember here, though, is that not everyone has sensitive skin and will run into these issues
These drugs are not magic and carry risks - GI issues, gallbladder problems, lean mass loss if protein intake is inadequate, and long-term unknowns require thoughtful prescribing, monitoring, and integration with strength training, proper nutrition, and sleep rather than replacement of these fundamentals
The challenge is that our natural supply dwindles dramatically as we get older
